How to perform use-error risk analysis for complex drug delivery devices How to perform use-error risk analysis for complex drug delivery devices Context In the realm of pharmaceutical and medical device development, human factors and operator qualification are paramount. The increasing complexity of drug delivery systems necessitates a focus on user interactions, particularly in avoiding use errors that could have significant clinical implications. Regulatory affairs (RA) professionals play a critical role in ensuring compliance with international standards such as ISO 14971, which provides a framework for risk management in the medical device sector, including methods like use-error risk analysis. Legal/Regulatory…

Task mapping and critical-user step identification for combination products Task Mapping and Critical-User Step Identification for Combination Products In the rapidly evolving field of regulatory affairs, particularly for combination products, a robust framework addressing human factors and use-error risk analysis is vital. This article will provide a structured explanation of the regulations, guidelines, and agency expectations pertinent to task mapping and critical-user step identification. Regulatory Affairs Context Combination products are therapeutic approaches that combine different modalities, such as drugs, devices, and biological products. With their complexity comes increased risk potential; hence, regulatory agencies enforce stringent guidelines to mitigate use-errors. Understanding…

Using FMEA for Human Factors and Use-Error Risk Analysis in Medical Devices Using FMEA for Human Factors and Use-Error Risk Analysis in Medical Devices In the dynamic field of medical device regulation, thorough analysis of human factors and potential use errors is paramount to ensure patient safety and compliance with applicable regulations. This article serves as a comprehensive guide for regulatory affairs professionals, detailing the use-error risk analysis, particularly utilizing Failure Mode and Effects Analysis (FMEA) methodology, to address human factors issues in medical device validation. Regulatory Context for Human Factors and Use-Error Risk Analysis Understanding the landscape of clinical…

Designing risk-based mitigation plans for critical use errors in injectors Designing risk-based mitigation plans for critical use errors in injectors Regulatory Affairs Context The application of regulatory frameworks to human factors engineering and risk management is critical in the lifecycle of medical devices, specifically injectors. Regulatory authorities such as the FDA, EMA, and MHRA stipulate stringent guidelines to assure that devices do not only function as intended but that they also account for human interaction. The use-error risk analysis serves as a fundamental mechanism to assess potential misuse and ensure the safety and effectiveness of injector systems. Legal/Regulatory Basis When…

Integrating use-error risk analysis into design reviews and DHF documentation Integrating use-error risk analysis into design reviews and DHF documentation The integration of use-error risk analysis into design reviews and Design History File (DHF) documentation is a critical aspect of Regulatory Affairs (RA) in the pharmaceutical and medical devices industries. Given the regulatory landscape in the US, EU, and UK, it is essential for Kharma professionals and others in RA to understand the guidelines and expectations set by regulatory agencies. This article provides a comprehensive overview of the regulatory context, legal basis, documentation requirements, review and approval workflows, and common…

Building robust use scenarios and task analyses for human factors studies Building robust use scenarios and task analyses for human factors studies Context Human factors and operator qualification are critical elements in the design and development of pharmaceutical products and medical devices. The primary goal is to optimize human interaction with systems to minimize the potential for use errors. Use-error risk analysis is a vital component of human factors studies, enabling the identification and mitigation of risks associated with the interaction between users and devices. As per regulatory guidelines, performing thorough use-error risk analyses and task mapping is essential to…

Prioritising critical-user steps for validation in high-risk device workflows Prioritising Critical-User Steps for Validation in High-Risk Device Workflows Context The role of Regulatory Affairs (RA) in the lifecycle of medical devices is paramount, especially when addressing high-risk workflows that involve the potential for use errors. Understanding use-error risk analysis, task mapping, and the identification of critical user steps is essential for ensuring compliance with regulatory expectations and safeguarding patient safety. This document provides a detailed examination of the relevant regulations, guidelines, and agency expectations applicable in the US, UK, and EU. Legal/Regulatory Basis The legal frameworks governing medical devices across…

Linking Use-Error Risk Analysis to Labeling, IFU, and Training Content Linking Use-Error Risk Analysis to Labeling, IFU, and Training Content In the ever-evolving landscape of pharmaceutical and medical device regulations, understanding how to effectively link use-error risk analysis to labeling, Instructions for Use (IFU), and training content is crucial. This article provides a comprehensive overview of the relevant regulations, guidelines, and agency expectations that inform the interaction between Regulatory Affairs (RA), Quality Assurance (QA), Quality Control (QC), and validation professionals in the context of human factors and operator qualification. Regulatory Context Human factors engineering and risk analysis are integral components…

Common mistakes in task mapping that lead to residual use-error risk Common mistakes in task mapping that lead to residual use-error risk Regulatory Affairs Context In the field of regulatory affairs, understanding and mitigating use-error risks is a paramount concern for both pharmaceutical and medical device professionals. As defined in ISO 14971, use-error refers to any unintended outcome that results from user’s misinterpretation or misuse of a product. These risks cannot be overlooked, especially given the potential regulatory and legal repercussions of product failures linked to human factors. Regulatory authorities in the US, UK, and EU emphasize the importance of…

Using hazard analysis tools to structure human factors risk discussions Using Hazard Analysis Tools to Structure Human Factors Risk Discussions Regulatory Affairs Context The integration of human factors into regulatory strategy is essential for pharmaceutical and medical device manufacturers. The systematic evaluation of use-error risk helps ensure that products are designed for optimal user interaction, thereby enhancing patient safety and product efficacy. Regulatory agencies such as the FDA, EMA, and MHRA emphasize the importance of understanding human factors to mitigate risks associated with use errors. This article presents a structured approach to use-error risk analysis grounded in relevant regulations, guidelines,…